NEW YORK — Nearly 80% of patients who received a Xen gel stent with IOP-lowering topical medication after surgery experienced an IOP of less than 18 mm Hg, but early interventions were needed in 20% of patients, according to a speaker here.
“Careful follow-up is necessary at 1 month as most failures, complications and need for medications clustered around this time,” Ramesh Ayyala, MD, FRCS, FRCOphth, said at the American Glaucoma Society annual meeting.
In a longitudinal retrospective study, 211 eyes underwent Xen (Allergan) implantation. At baseline, the mean IOP (Read more...)
Uncategorized